Healthcare Cost and Utilization Among U.S. Patients with Relapsed/Refractory Systemic Light Chain Amyloidosis (RRAL)
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2257
https://www.valueinhealthjournal.com/article/S1098-3015(16)33623-3/fulltext
Title :
Healthcare Cost and Utilization Among U.S. Patients with Relapsed/Refractory Systemic Light Chain Amyloidosis (RRAL)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33623-3&doi=10.1016/j.jval.2016.09.2257
First page :
A741
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2143